West Pharmaceutical Services, Inc. (WST)
| Market Cap | 20.16B |
| Revenue (ttm) | 3.02B |
| Net Income (ttm) | 491.70M |
| Shares Out | 71.94M |
| EPS (ttm) | 6.75 |
| PE Ratio | 41.51 |
| Forward PE | 37.56 |
| Dividend | $0.88 (0.31%) |
| Ex-Dividend Date | Nov 12, 2025 |
| Volume | 645,692 |
| Open | 282.01 |
| Previous Close | 281.77 |
| Day's Range | 278.23 - 283.52 |
| 52-Week Range | 187.43 - 348.90 |
| Beta | 1.17 |
| Analysts | Strong Buy |
| Price Target | 346.78 (+23.75%) |
| Earnings Date | Oct 23, 2025 |
About WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc... [Read more]
Financial Performance
In 2024, WST's revenue was $2.89 billion, a decrease of -1.92% compared to the previous year's $2.95 billion. Earnings were $492.70 million, a decrease of -16.97%.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for WST stock is "Strong Buy." The 12-month stock price target is $346.78, which is an increase of 23.75% from the latest price.
News
West Pharmaceutical Services, Inc. (WST) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
West Pharmaceutical Services, Inc. (WST) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
West Pharmaceutical: Back To Growth
West Pharmaceutical Services is rated a buy, supported by strong Q3 results, raised guidance, and a resilient long-term growth thesis. WST's focus on high-value proprietary elastomer components and se...
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...
West Pharmaceutical Services, Inc. (WST) Presents at Stephens Annual Investment Conference 2025 Transcript
West Pharmaceutical Services, Inc. ( WST) Stephens Annual Investment Conference 2025 November 20, 2025 12:00 PM EST Company Participants Robert McMahon - Senior VP & CFO Shane Campbell - SVP & Chief ...
West Pharmaceutical Services, Inc. (WST) Presents at Jefferies London Healthcare Conference 2025 Transcript
West Pharmaceutical Services, Inc. ( WST) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST Company Participants Robert McMahon - Senior VP & CFO Conference Call Participants ...
West Pharmaceutical Services, Inc. (WST) Presents at UBS Global Healthcare Conference 2025 Transcript
West Pharmaceutical Services, Inc. ( WST) UBS Global Healthcare Conference 2025 November 11, 2025 9:30 AM EST Company Participants Robert McMahon - Senior VP & CFO Presentation Unknown Analyst Joinin...
Artisan Global Opportunities Fund Q3 2025 Portfolio Update
During the quarter, we initiated new positions in Spotify, L3Harris Technologies and Insmed. We also added to 3i Group, West Pharmaceutical and Amazon during the quarter. We ended our investment campa...
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
EXTON, Pa. , Oct. 27, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the launch of its...
West to Participate in Upcoming Investor Conferences
EXTON, Pa. , Oct. 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will pres...
Why West Pharmaceutical Services Stock Was Blasting Higher on Thursday
It was a beat-and-raise third quarter for the healthcare services specialist. It experienced broad growth throughout its product and service offerings.
West Pharmaceutical Services, Inc. (WST) Q3 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2025 Earnings Call October 23, 2025 8:00 AM EDT Company Participants John Sweeney - Head of Investor Relations Eric Green - Non-Independent Chair of t...
West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand
West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company's third-quarter 2025 earnings surpassed analyst estimate...
West Pharma boosts annual profit forecast on strong demand for its drug components
Medical equipment maker West Pharmaceutical raised its annual profit forecast on Thursday, after posting better-than-expected results for the third quarter, banking on strong demand for its components...
West Reports Third-Quarter 2025 Results
- Delivered solid growth across Proprietary Products and Contract Manufacturing Segments - - Achieved double-digit growth in HVP Components - - Strengthened executive leadership team, including recen...
West Pharmaceutical Services: HVP Moat Cum GLP-1 And Biologics Tailwinds Reinforce Upward Momentum
West Pharmaceutical Services earns a Buy rating with a $320 price target, reflecting ~18% upside with strong long-term growth prospects. WST's high-value product mix is expanding, driving margin growt...
West to Host Third-Quarter 2025 Conference Call
EXTON, Pa. , Oct. 9, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will relea...
Top 50 High-Quality Dividend Growth Stocks For October 2025
I track a universe of 50 high-quality dividend growth stocks to identify opportune investments based on valuation and future return potential. As of October 2, 2025, 22 stocks offer attractive future ...
Top 15 High-Growth Dividend Stocks For October 2025
The Top 15 High-Growth Dividend Stock list for October 2025 targets a 12% long-term return, despite underperforming SPY and VIG in September. These 15 stocks offer a 1.4% average yield and have grown ...
West Pharmaceutical Services, Inc. (WST) Presents at Bank of America Global Healthcare Conference 2025 Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Bank of America Global Healthcare Conference 2025 September 24, 2025 10:05 AM EDT Company Participants Eric Green - Non-Independent Chair of the Board, P...
Top 50 High-Quality Dividend Stocks For September 2025
I track a universe of 50 high-quality dividend growth stocks to identify attractive investment opportunities based on valuation and future return potential. My custom valuation model highlights 23 sto...
West Pharmaceutical Services, Inc. (WST) Presents At Wells Fargo 2025 Healthcare Conference (Transcript)
West Pharmaceutical Services, Inc. (WST) Presents At Wells Fargo 2025 Healthcare Conference (Transcript)
Best Dividend Aristocrats For September 2025
Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 A...
West to Participate in Upcoming Investor Conferences in September 2025
EXTON, Pa. , Aug. 21, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will pre...
Top 50 High-Quality Dividend Stocks For August 2025
My investable universe of 50 high-quality dividend growth stocks aims to identify attractive opportunities based on valuation and future return potential. Currently, 20 stocks offer an estimated futur...